What is the address of ORTHO.GENT IMMO?

The registered office of ORTHO.GENT IMMO is located at Amandelboomlaan 16, 9030 Gent.

Is ORTHO.GENT IMMO still active?

Yes. According to the CBE (2 November 2026) ORTHO.GENT IMMO is active, legal situation “Normale toestand”, started on 29 June 2022.

Is ORTHO.GENT IMMO registered on Peppol?

Yes, ORTHO.GENT IMMO is registered on the Peppol network with ID 0208:0787817964.

What is the enterprise number of ORTHO.GENT IMMO?

The enterprise number of ORTHO.GENT IMMO is BE0787817964.

When was ORTHO.GENT IMMO founded?

ORTHO.GENT IMMO was founded on 29 June 2022.

Who are the directors of ORTHO.GENT IMMO?

According to the 2025 annual accounts, the directors of ORTHO.GENT IMMO are: Koen Liekens, Hans Stefan Van der Bracht, Pieter Desiré Beekman, Alexander Schepens.

Is ORTHO.GENT IMMO a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 29 June 2022; 4 annual accounts filed, latest fiscal year 2025; 4 directors known from the annual account.

How much profit did ORTHO.GENT IMMO make in 2025?

ORTHO.GENT IMMO posted a profit after taxes of € 90,465 in financial year 2025.

What is the revenue of ORTHO.GENT IMMO?

As a small company, ORTHO.GENT IMMO is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 175,143.

ORTHO.GENT IMMO (Private Limited) - Gent - BE0787817964

Dossier ORTHO.GENT IMMO, printed on 2 November 2026 from databakkes.be/en/0787817964/ortho-gent-immo. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 48 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

ORTHO.GENT IMMO from Gent, company number BE0787817964, closed financial year 2025 with a result of € 90,465 after tax. For that financial year ORTHO.GENT IMMO recorded a gross margin of € 175,143 and equity of € 157,967. Compared with financial year 2024, the result moved from € 43,130 to € 90,465. Profitable, and profit is growing. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 24, 2026.

What it is worth Growing

€ 157,967

▲ 33% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 90,465

▲ 110% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 35,380

▲ 30% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 50,994 paid out

56 % of the profit went to the shareholders, the rest stayed in the company.

Debts at end 2025

Bank debt ≈ 13 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 913,848

▼ 7% vs 2024

€ 70,981 is repaid this year. At this pace the long-term loan is gone in ≈ 13 years.

Taxes

€ 2,932

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ -14,741 Gross margin 2022: € -14,741 First fiscal year in the series	€ 72,130 Gross margin 2023: € 72,130 ▲ € 86,871 vs 2022 (€ -14,741) Favourable step	€ 99,577 Gross margin 2024: € 99,577 ▲ 38% vs 2023 (€ 72,130) Favourable step	€ 175,143 Gross margin 2025: € 175,143 ▲ 76% vs 2024 (€ 99,577) Favourable step	▲ 76%
Profit after taxes	€ -39,965 Profit after taxes 2022: € -39,965 First fiscal year in the series	€ 47,831 Profit after taxes 2023: € 47,831 ▲ € 87,796 vs 2022 (€ -39,965) Favourable step	€ 43,130 Profit after taxes 2024: € 43,130 ▼ 10% vs 2023 (€ 47,831) Unfavourable step	€ 90,465 Profit after taxes 2025: € 90,465 ▲ 110% vs 2024 (€ 43,130) Favourable step	▲ 110%
Equity	€ 27,535 Equity 2022: € 27,535 First fiscal year in the series	€ 75,366 Equity 2023: € 75,366 ▲ 174% vs 2022 (€ 27,535) Favourable step	€ 118,496 Equity 2024: € 118,496 ▲ 57% vs 2023 (€ 75,366) Favourable step	€ 157,967 Equity 2025: € 157,967 ▲ 33% vs 2024 (€ 118,496) Favourable step	▲ 33%
Total debts	€ 522,151 Total debts 2022: € 522,151 First fiscal year in the series	€ 1,009,298 Total debts 2023: € 1,009,298 ▲ 93% vs 2022 (€ 522,151) Unfavourable step	€ 977,567 Total debts 2024: € 977,567 ▼ 3% vs 2023 (€ 1,009,298) Favourable step	€ 916,779 Total debts 2025: € 916,779 ▼ 6% vs 2024 (€ 977,567) Favourable step	▼ 6%
Cash	€ 54,126 Cash 2022: € 54,126 First fiscal year in the series	€ 36,083 Cash 2023: € 36,083 ▼ 33% vs 2022 (€ 54,126) Unfavourable step	€ 27,147 Cash 2024: € 27,147 ▼ 25% vs 2023 (€ 36,083) Unfavourable step	€ 35,380 Cash 2025: € 35,380 ▲ 30% vs 2024 (€ 27,147) Favourable step	▲ 30%
Land & buildings	€ 210,000 Land & buildings 2022: € 210,000 First fiscal year in the series	€ 1,046,074 Land & buildings 2023: € 1,046,074 ▲ € 836,074 vs 2022 (€ 210,000) Unchanged	€ 1,066,459 Land & buildings 2024: € 1,066,459 ▲ 2% vs 2023 (€ 1,046,074) Unchanged	€ 1,037,975 Land & buildings 2025: € 1,037,975 ▼ 3% vs 2024 (€ 1,066,459) Unchanged	▼ 3%
Retained profit	€ -39,965 Retained profit 2022: € -39,965 First fiscal year in the series	€ 7,866 Retained profit 2023: € 7,866 ▲ € 47,831 vs 2022 (€ -39,965) Favourable step	€ 50,996 Retained profit 2024: € 50,996 ▲ € 43,130 vs 2023 (€ 7,866) Favourable step	€ 90,467 Retained profit 2025: € 90,467 ▲ 77% vs 2024 (€ 50,996) Favourable step	▲ 77%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 50,994 Dividend 2025: € 50,994 Unchanged (€ 0) Unchanged
Bank debt	€ 508,705 Bank debt 2022: € 508,705 First fiscal year in the series	€ 997,824 Bank debt 2023: € 997,824 ▲ 96% vs 2022 (€ 508,705) Unfavourable step	€ 977,567 Bank debt 2024: € 977,567 ▼ 2% vs 2023 (€ 997,824) Favourable step	€ 913,848 Bank debt 2025: € 913,848 ▼ 7% vs 2024 (€ 977,567) Favourable step	▼ 7%
Balance sheet total	€ 549,686 Balance sheet total 2022: € 549,686 First fiscal year in the series	€ 1,084,664 Balance sheet total 2023: € 1,084,664 ▲ 97% vs 2022 (€ 549,686) Unchanged	€ 1,096,063 Balance sheet total 2024: € 1,096,063 ▲ 1% vs 2023 (€ 1,084,664) Unchanged	€ 1,074,746 Balance sheet total 2025: € 1,074,746 ▼ 2% vs 2024 (€ 1,096,063) Unchanged	▼ 2%

Key figures of ORTHO.GENT IMMO, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to ORTHO.GENT IMMO?

What happened at ORTHO.GENT IMMO in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 24, 2026 New annual accounts for financial year 2025: profit of € 90,465 (▲ 110% vs 2024). Source: NBB ↗
Jun 29, 2022 New establishment in Gent. KBO
2022 Koen Liekens became a director. NBB
2022 Hans Stefan Van der Bracht became a director. NBB
2022 Pieter Desiré Beekman became a director. NBB
2022 Alexander Schepens became a director. NBB
Jun 29, 2022 Start of the company according to the CBE. KBO

In short

From € 39,965 loss in 2022 to € 90,465 profit in 2025.

Paid € 28,932 in corporate taxes since 2022.

Best year ever: 2025, with € 90,465 profit.

Paid out € 50,994 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Koen Liekens Hans Stefan Van der Bracht Pieter Desiré Beekman Alexander Schepens

Dr. Koen Liekens - Orthopedie

DR.VAN dER BRACHT HANS

ORTHO.GENT IMMO

BV Dr. Pieter Beekman, orthopedische heelkunde en Dr. Venita D’Cruz, gastro-enterologie

Behind ORTHO.GENT IMMO are Koen Liekens, Hans Stefan Van der Bracht, Pieter Desiré Beekman and Alexander Schepens. Koen Liekens is also behind Dr. Koen Liekens - Orthopedie. Hans Stefan Van der Bracht is also behind DR.VAN dER BRACHT HANS. Pieter Desiré Beekman is also behind BV Dr. Pieter Beekman, orthopedische heelkunde en Dr. Venita D’Cruz, gastro-enterologie. Alexander Schepens is also behind Dr. A. Schepens, Orthopedie - Dr. T. Raemdonck, Oftalmologie.

Directors

According to the 2025 annual accounts

Koen Liekens

Director

Also active at: Dr. Koen Liekens - Orthopedie

since 2022

Hans Stefan Van der Bracht

Director

Also active at: DR.VAN dER BRACHT HANS

since 2022

Pieter Desiré Beekman

Director

Also active at: BV Dr. Pieter Beekman, orthopedische heelkunde en Dr. Venita D’Cruz, gastro-enterologie

since 2022

Alexander Schepens

Director

Also active at: Dr. A. Schepens, Orthopedie - Dr. T. Raemdonck, Oftalmologie

since 2022

Establishments

Establishment units

Physical locations of this company

Registered office

Amandelboomlaan 16

9030 Gent

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

Dr. A. Schepens, Orthopedie - Dr. T. Raemdonck, Oftalmologie same network

€ 372,727 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0787.817.964
VAT number: BE 0787.817.964
Registered office: Amandelboomlaan 16, 9030 Gent
Names & denominations: ORTHO.GENT IMMO
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 29 June 2022
Peppol: Active · Active since 2 Sept 2025

View on CBE Public ↗ Annual accounts (NBB) ↗

ORTHO.GENT IMMO

Warning lights

Financials

What happened to ORTHO.GENT IMMO?

Management

Directors

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions